- A 55-year-old patient with a history of myocardial infarction and a baseline QTc interval of 460 ms requires antipsychotic treatment for severe agitation. Which agent carries a black box warning for QTc prolongation and should be considered a relative contraindication in this patient?
Answer: Thioridazine
The correct answer is A. Several antipsychotics can prolong the QTc interval, but the risk varies significantly. Thioridazine, a low-potency first-generation antipsychotic, is notorious for this effect and carries a black box warning advising against its use unless other agents have failed. It is considered one of the highest-risk antipsychotics for QTc prolongation. Ziprasidone also carries a warning. In contrast, aripiprazole and lurasidone are associated with a very low risk of QTc prolongation, making them safer choices in patients with cardiac concerns.
- A 35-year-old patient with schizophrenia has been stable on olanzapine for two years. At a routine follow-up, their fasting blood glucose is 135 mg/dL and HbA1c is 7.2%. Their BMI has increased from 26 to 33 over the treatment period. Which of the following antipsychotics would be the most appropriate switch to mitigate these metabolic effects while maintaining efficacy?
Answer: Aripiprazole
The correct answer is D. The patient is experiencing significant metabolic side effects (new-onset diabetes, weight gain) from olanzapine, which carries one of the highest metabolic risks among second-generation antipsychotics (SGAs). Aripiprazole, along with ziprasidone and lurasidone, is considered to have a much lower risk of metabolic disturbances. Clozapine has a metabolic risk profile similar to or worse than olanzapine. Quetiapine and risperidone carry an intermediate metabolic risk, making them less ideal choices than aripiprazole for a patient who has already developed metabolic syndrome.
- A physician is selecting a typical antipsychotic for a frail elderly patient, aiming to minimize the risk of extrapyramidal symptoms but recognizing the trade-off with other side effects. Which statement accurately compares the expected side effect profiles of chlorpromazine and haloperidol?
Answer: Haloperidol has a higher risk of EPS; chlorpromazine has a higher risk of sedation and orthostatic hypotension.
The correct answer is A. This question tests the concept of FGA potency. Haloperidol is a high-potency FGA, meaning it binds tightly to D2 receptors with little activity at other receptors. This leads to a high risk of EPS but a lower risk of sedation (H1 blockade), orthostatic hypotension (alpha-1 blockade), and anticholinergic effects (M1 blockade). Chlorpromazine is a low-potency FGA with less D2 affinity (lower EPS risk) but significant antagonist activity at H1, alpha-1, and M1 receptors, resulting in a higher risk of sedation, orthostatic hypotension, and anticholinergic effects.
- A 38-year-old male with treatment-resistant schizophrenia, well-controlled on clozapine for three years, presents to the emergency department with a new-onset seizure. His clozapine level is found to be twice his usual therapeutic level. The patient denies any changes in his clozapine regimen but reports he was recently treated for a urinary tract infection. Concomitant use of which antibiotic most likely explains this presentation?
Answer: Ciprofloxacin
The correct answer is B. This is a multi-step problem. Seizures are a known, dose-dependent side effect of clozapine. A doubled clozapine level points to a pharmacokinetic interaction. Clozapine is primarily metabolized by the CYP1A2 enzyme. Ciprofloxacin is a potent inhibitor of CYP1A2. Its co-administration would decrease clozapine metabolism, leading to a significant rise in plasma levels and increased risk of adverse effects like seizures. The other listed antibiotics do not have a clinically significant inhibitory effect on CYP1A2.
- A 68-year-old patient with a 30-year history of schizophrenia treated with various typical antipsychotics presents with persistent, involuntary choreoathetoid movements of the face and tongue. The movements persist despite discontinuation of the offending agent 6 months ago. The underlying pathophysiology of this condition is most closely related to what long-term change in the central nervous system?
Answer: Upregulation and supersensitivity of postsynaptic D2 receptors
The correct answer is B. The patient's presentation is classic for tardive dyskinesia (TD), a delayed-onset movement disorder caused by long-term use of dopamine receptor antagonists. The leading hypothesis for its pathophysiology is that chronic blockade of D2 receptors in the nigrostriatal pathway leads to a compensatory upregulation in the number and sensitivity of these receptors. This renders them 'supersensitive' to dopamine, resulting in the hyperkinetic movements characteristic of TD. Downregulation of dopamine neurons is characteristic of Parkinson's disease. Enhanced 5-HT2A antagonism is thought to be protective against EPS. Chronic M1 blockade is associated with anticholinergic side effects.
- A new antipsychotic, Drug X, has a receptor binding profile showing high affinity for D2 and 5-HT2A receptors. Its dissociation constant from the D2 receptor is significantly faster than that of haloperidol. It has negligible affinity for H1, M1, and alpha-1 adrenergic receptors. Based on this profile, which statement most accurately predicts its clinical characteristics?
Answer: A low risk of extrapyramidal symptoms and a low risk of sedation.
The correct answer is B. The combination of D2 and 5-HT2A antagonism is characteristic of an atypical antipsychotic. The 'fast-off' property from the D2 receptor is associated with a lower risk of extrapyramidal symptoms (EPS) compared to tightly-binding agents like haloperidol. The negligible affinity for H1 receptors predicts a low risk of sedation and weight gain. Negligible M1 affinity predicts a lack of anticholinergic effects. The combination of 5-HT2A antagonism and fast D2 dissociation also mitigates the risk of hyperprolactinemia.
- A 29-year-old patient started on risperidone three weeks ago for bipolar disorder reports an intense inner restlessness and an inability to sit still, constantly pacing in the examination room. The dose of risperidone was recently increased. After ruling out worsening of the underlying psychiatric condition, what is the most appropriate next pharmacological step?
Answer: Add propranolol
The correct answer is B. The patient is describing akathisia, a common and highly distressing extrapyramidal symptom characterized by subjective and objective restlessness. First-line treatments for akathisia include beta-blockers (like propranolol), benzodiazepines, and mirtazapine. While benztropine is used for other EPS like dystonia and parkinsonism, it is less effective for akathisia. Increasing the risperidone dose or switching to a high-potency typical antipsychotic like haloperidol would likely worsen the akathisia.
- A clinician is evaluating a patient who has been treated with risperidone for several years. Which of the following presentations is most consistent with tardive dyskinesia (TD) rather than an acute or subacute extrapyramidal symptom?
Answer: Repetitive, involuntary puckering of the lips and worm-like movements of the tongue.
The correct answer is C. This question requires differentiating the various forms of EPS based on their clinical presentation and typical timeline. Tardive dyskinesia is a late-onset (usually after months to years of treatment) syndrome characterized by involuntary, repetitive, choreoathetoid movements, classically affecting the orofacial region (lip-smacking, tongue protrusion). Choice A describes acute dystonia. Choice B describes akathisia. Choice D describes drug-induced parkinsonism. All three are typically earlier-onset phenomena than TD.
- A patient with chronic schizophrenia treated with fluphenazine develops disabling orofacial tardive dyskinesia. Switching to clozapine provides only minimal improvement. The addition of which medication is most likely to provide symptomatic relief by reversibly inhibiting vesicular monoamine transporter 2 (VMAT2)?
Answer: Valbenazine
The correct answer is D. Valbenazine (and deutetrabenazine) are inhibitors of vesicular monoamine transporter 2 (VMAT2). This transporter is responsible for packaging monoamines, including dopamine, into presynaptic vesicles for release. By inhibiting VMAT2, these drugs reduce dopamine release, thereby decreasing the stimulation of supersensitive postsynaptic D2 receptors thought to cause tardive dyskinesia. Benztropine, an anticholinergic, can worsen TD. Propranolol is used for akathisia. Levodopa, a dopamine precursor, would significantly exacerbate TD.
- A 30-year-old female patient on a stable dose of a second-generation antipsychotic for schizoaffective disorder complains of amenorrhea and galactorrhea. These symptoms are most likely caused by potent blockade of the tuberoinfundibular dopamine pathway by which agent?
Answer: Risperidone
The correct answer is C. Dopamine in the tuberoinfundibular pathway normally inhibits prolactin release. Blockade of D2 receptors in this pathway disinhibits prolactin, leading to hyperprolactinemia, which can cause amenorrhea, galactorrhea, and sexual dysfunction. Among the second-generation antipsychotics, risperidone (and its active metabolite, paliperidone) is the most notorious for causing significant hyperprolactinemia due to its potent D2 antagonism. Quetiapine, aripiprazole, and clozapine are considered 'prolactin-sparing' due to weaker or partial agonist D2 activity.
- A patient taking chlorpromazine complains of persistent dry mouth, constipation, and blurred vision. These side effects are best explained by the drug's antagonist activity at which receptor?
Answer: Muscarinic M1
The correct answer is C. The constellation of dry mouth (decreased salivation), constipation (decreased GI motility), and blurred vision (cycloplegia) is a classic anticholinergic syndrome. These effects are caused by blockade of muscarinic acetylcholine receptors. Low-potency first-generation antipsychotics, like chlorpromazine, have significant M1 antagonist properties. H1 blockade causes sedation and weight gain. Alpha-1 blockade causes orthostatic hypotension. D2 blockade is responsible for the therapeutic effect and EPS.
- A patient with treatment-resistant schizophrenia is being initiated on clozapine. Which monitoring plan is essential and unique to this medication due to its risk of a rare but life-threatening hematological adverse effect?
Answer: Weekly absolute neutrophil count (ANC) for the first 6 months
The correct answer is C. Clozapine carries a black box warning for severe neutropenia (agranulocytosis). To mitigate this risk, a strict monitoring protocol via a Risk Evaluation and Mitigation Strategy (REMS) program is mandatory. This involves checking the absolute neutrophil count (ANC) weekly for the first six months, then bi-weekly for the next six months, and monthly thereafter. While monitoring ECGs, metabolic parameters, and LFTs is important with clozapine and other antipsychotics, the stringent, mandatory ANC monitoring is the most critical and unique requirement for this specific drug.
- A 45-year-old patient with treatment-resistant schizophrenia is well-stabilized on clozapine 400 mg/day. The patient, a heavy smoker, is admitted to a smoke-free inpatient psychiatric unit. After five days, the patient becomes increasingly sedated, hypotensive, and dizzy. What is the most likely pharmacokinetic explanation for these new symptoms?
Answer: Decreased induction of CYP1A2, leading to increased clozapine levels
The correct answer is B. Polycyclic aromatic hydrocarbons in tobacco smoke are potent inducers of the cytochrome P450 enzyme CYP1A2, which is the primary enzyme responsible for clozapine metabolism. When a patient who smokes heavily is in a smoke-free environment, the induction of CYP1A2 ceases. This leads to a rapid decrease in clozapine metabolism and a subsequent increase in its plasma concentration, potentially to toxic levels, causing sedation, hypotension, and seizures. Nicotine withdrawal typically causes agitation and anxiety, not sedation.
- A patient stabilized on haloperidol for schizophrenia develops a fever of 40°C (104°F), severe 'lead-pipe' muscle rigidity, altered mental status, and autonomic instability. The patient's psychiatrist recently added fluoxetine for comorbid depression. Which clinical feature is most specific for Neuroleptic Malignant Syndrome (NMS) and helps to differentiate it from serotonin syndrome in this scenario?
Answer: Severe, diffuse 'lead-pipe' muscle rigidity
The correct answer is C. While hyperthermia and altered mental status are common to both Neuroleptic Malignant Syndrome (NMS) and serotonin syndrome, the quality of the muscle involvement is a key differentiator. NMS is characterized by severe, diffuse, 'lead-pipe' rigidity. In contrast, serotonin syndrome typically presents with neuromuscular excitability, such as hyperreflexia, myoclonus (brief, involuntary muscle jerking), and tremor, not the sustained rigidity seen in NMS.
- An inpatient psychiatric team is initiating ziprasidone for a patient with an acute manic episode. The clinical pharmacist emphasizes a specific counseling point to the patient and nursing staff as being critical for achieving therapeutic drug levels. What is this counseling point?
Answer: The medication should be administered with a meal of at least 500 calories.
The correct answer is B. The oral bioavailability of ziprasidone is highly dependent on administration with food. Taking it with a meal of at least 500 calories can double the absorption compared to taking it in a fasted state. Failure to adhere to this can result in subtherapeutic plasma concentrations and a false impression of treatment failure. While grapefruit juice interactions and ECG monitoring (for QTc prolongation, not agranulocytosis) are relevant, the food requirement is the most critical factor for ensuring adequate absorption and efficacy.
- A 22-year-old patient is brought to the emergency department with an involuntary upward deviation of the eyes and twisting of the neck that began two hours after receiving an intramuscular injection of haloperidol. Which pharmacological agent is the most appropriate initial treatment for this condition?
Answer: Intramuscular benztropine
The correct answer is A. The patient is experiencing an acute dystonic reaction, a type of extrapyramidal symptom characterized by sustained muscle contractions. This is a medical emergency that requires prompt treatment with an anticholinergic agent, such as benztropine, or an antihistamine with anticholinergic properties, like diphenhydramine. Propranolol is a first-line treatment for akathisia. Dantrolene is used to treat neuroleptic malignant syndrome. Lorazepam can be an adjunctive treatment but is not the primary intervention for reversing the dystonia.
- An elderly patient treated with haloperidol for delirium develops a resting tremor, bradykinesia, and cogwheel rigidity three weeks after initiation of therapy. These symptoms are most likely caused by the drug's antagonist activity at D2 receptors in which dopamine pathway?
Answer: Nigrostriatal
The correct answer is D. The nigrostriatal pathway projects from the substantia nigra to the striatum and is a key component of the basal ganglia motor loop, which regulates voluntary movement. Blockade of D2 receptors in this pathway disrupts normal motor function, leading to drug-induced parkinsonism, characterized by tremor, rigidity, and bradykinesia. The mesolimbic pathway is the primary target for antipsychotic efficacy. The mesocortical pathway is associated with negative and cognitive symptoms of schizophrenia. The tuberoinfundibular pathway regulates prolactin secretion.
- A physician is choosing a second-generation antipsychotic for a 19-year-old patient with first-episode psychosis. The patient has a strong family history of type 2 diabetes and is overweight (BMI 29). Which pair of antipsychotics represents the highest and lowest risk, respectively, for causing further weight gain and metabolic dysregulation?
Answer: Olanzapine (highest); Lurasidone (lowest)
The correct answer is B. Second-generation antipsychotics vary widely in their metabolic risk. Olanzapine and clozapine are consistently associated with the highest risk of weight gain, dyslipidemia, and insulin resistance. Lurasidone, ziprasidone, and aripiprazole are considered to have the lowest metabolic risk. Risperidone, paliperidone, and quetiapine fall into an intermediate-risk category. Therefore, the pair with the greatest contrast between highest and lowest risk is olanzapine and lurasidone.
- The lower incidence of extrapyramidal symptoms with second-generation antipsychotics (SGAs) compared to first-generation antipsychotics (FGAs) is a defining feature of their 'atypicality.' Which neurochemical property is thought to be a primary contributor to this improved motor side effect profile?
Answer: Potent serotonin 5-HT2A receptor antagonism that exceeds D2 receptor antagonism
The correct answer is A. The 'serotonin-dopamine hypothesis of atypicality' proposes that potent 5-HT2A antagonism is key to the reduced EPS liability of SGAs. Serotonin normally inhibits dopamine release in the nigrostriatal pathway. By blocking 5-HT2A receptors, SGAs disinhibit this pathway, leading to increased dopamine release that can counteract the effects of D2 blockade in the same region, thereby mitigating the risk of EPS. The other options describe mechanisms not characteristic of the SGA class.
- Aripiprazole's unique clinical profile, including a low incidence of both hyperprolactinemia and motor side effects, is attributed to its distinct mechanism as a D2 partial agonist. How does this mechanism differ from that of a full D2 antagonist like haloperidol?
Answer: It provides a ceiling effect on dopamine antagonism, acting as a functional antagonist in hyperdopaminergic states and a functional agonist in normodopaminergic states.
The correct answer is A. As a partial agonist, aripiprazole has intrinsic activity at the D2 receptor but produces a submaximal response compared to the full agonist, dopamine. In the mesolimbic pathway, where dopamine is thought to be excessive in psychosis, aripiprazole competes with dopamine and reduces net receptor stimulation (acting as a functional antagonist). In the nigrostriatal and tuberoinfundibular pathways, where dopamine levels are normal, it provides sufficient stimulation to avoid the severe EPS and hyperprolactinemia caused by full antagonists (acting as a functional agonist). This concept is often referred to as 'dopamine system stabilization.'
